Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

JAK2 mutation: an aid in the diagnosis of occult myeloproliferative neoplasms in patients with major intraabdominal vein thrombosis and normal blood counts.

The Israel Medical Association journal : IMAJ - 1 Nov 2013

Sarid Nadav, Eshel Rinat, Rahamim Einam, Carmiel Michal, Kirgner Ilya, Shpringer Meirav, Trestman Svetlana, Marilus Rafi, Perry Chava, Polliack Aaron, Naparstek Ella, Herishanu Yair

Abstract excerpt

BACKGROUND: Janus kinase-2 (JAK2) is mutated in a high proportion of patients with polycythemia vera and in a smaller number with essential thrombocythemia and primary myelofibrosis. Mutated JAK2 is an important diagnostic marker for myeloproliferative neoplasm (MPN) and may also play a major role in the pathogenesis of MPN. OBJECTIVES: To evaluate the prevalence of mutated JAK2 (JAK2-V617F) among patients with...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Age Factors
Share to Blood Cell Count

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Janus Kinase 2

Share to Myeloproliferative Disorders

Share to Prevalence

Share to Real-Time Polymerase Chain Reaction

Share to Splenomegaly

Share to Venous Thrombosis

Source

Identifiers

PMID: 24511651

Genes

JAK2

Variants

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

JAK2 mutation: an aid in the diagnosis of occult myeloproliferative neoplasms in patients with major intraabdominal vein thrombosis and normal blood counts.PMID 24511651Read ↗

Undiagnosed myeloproliferative disease in cases of intra-abdominal thrombosis: the utility of the JAK2 617F mutation.Semantic proximity Read ↗

The JAK2 V617F mutation frequently occurs in patients with portal and mesenteric venous thrombosis.Semantic proximity Read ↗

Splanchnic venous thrombosis driven by a constitutively activated JAK2 V617F philadelphia-negative myeloproliferative neoplasm: a case report.Semantic proximity Read ↗

Vascular events in Korean patients with myeloproliferative neoplasms and their relationship to JAK2 mutation.Semantic proximity Read ↗

Prevalence of overt myeloproliferative neoplasms and JAK2 V617F mutation in Korean patients with splanchnic vein thrombosis.Semantic proximity Read ↗

Exploring the Molecular Aspects of Myeloproliferative Neoplasms Associated with Unusual Site Vein Thrombosis: Review of the Literature and Latest Insights.Semantic proximity Read ↗

Low prevalence of JAK2 V617F mutation in patients with thrombosis and normal blood counts: a retrospective impact study.Semantic proximity Read ↗

The JAK2(V617F) tyrosine kinase mutation identifies clinically latent myeloproliferative disorders in patients presenting with hepatic or portal vein thrombosis.Semantic proximity Read ↗

JAK2 V617F mutation, mesenteric vein thrombosis, and myeloproliferative disorders.Semantic proximity Read ↗

JAK2 V617F mutation in patients with catastrophic intra-abdominal thromboses.Semantic proximity Read ↗

The prevalence of the activating JAK2 tyrosine kinase mutation in chronic porto-splenomesenteric venous thrombosis.Semantic proximity Read ↗

Diagnostic value of the JAK2 V617F mutation for latent chronic myeloproliferative disorders in patients with Budd-Chiari syndrome and/or portal vein thrombosis.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.